| |
Apr 25, 2013
NeoGenomics Reports Record Quarterly Revenue of $15.7 Million, Adjusted EBITDA of $1.8 Million and 46.3% Gross Margin for the First Quarter
|
79.7 KB |
|
| |
Apr 17, 2013
NeoGenomics Schedules its Q1 2013 Earnings Release for April 25, 2013
|
31.1 KB |
|
| |
Feb 28, 2013
NeoGenomics Announces Pricing of $9.5 Million Public Offering
|
43.4 KB |
|
| |
Feb 14, 2013
NeoGenomics Reports 181% Increase in Adjusted EBITDA on 38% Revenue Growth and Achieves Profitability in 2012
|
105.9 KB |
|
| |
Feb 5, 2013
NeoGenomics Schedules its Q4 and Full Year 2012 Earnings Release for February 14, 2013
|
31.1 KB |
|
| |
Dec 17, 2012
NeoGenomics Validates and Launches NeoSITE™ Barrett's Esophagus FISH Test for Surveillance and Diagnosis of High Grade Dysplasia/Esophageal Cancer
|
57.4 KB |
|
| |
Dec 6, 2012
NeoGenomics Announces NASDAQ Capital Market Listing
|
53.4 KB |
|
| |
Oct 31, 2012
NeoGenomics Reports 42% Test Volume Growth, 26% Revenue Growth and 22% Increase in Adjusted EBITDA for the Third Quarter 2012
|
90.0 KB |
|
| |
Oct 23, 2012
NeoGenomics Schedules its Q3 2012 Earnings Release for October 31, 2012
|
31.1 KB |
|
| |
Sep 13, 2012
NeoGenomics Develops and Implements Proprietary Method for Automating and Interpreting Fluorescence In-Situ Hybridization Test Data
|
58.9 KB |
|
| |
Aug 6, 2012
NeoGenomics Launches NeoTYPE™ Prognostic Panel for Chronic Lymphocytic Leukemia; Includes First U.S. Clinical Molecular Test for SF3B1 Mutations
|
55.6 KB |
|
| |
Jul 19, 2012
NeoGenomics Reports 49% Revenue Growth, Adjusted EBITDA of $1.9 million and Net Income of $550,000 for the Second Quarter 2012
|
89.8 KB |
|
| |
Jul 18, 2012
NeoGenomics Significantly Expands Molecular Testing Menu and Launches NeoTYPE™ Cancer Profile Panels
|
62.2 KB |
|
| |
Jul 9, 2012
NeoGenomics Schedules its Q2 2012 Earnings Release for July 19, 2012
|
31.1 KB |
|
| |
Apr 25, 2012
NeoGenomics Reports 72% Revenue Growth, 85% Gross Profit Growth and $1.5 Million Increase in Net Income for Q1 2012
|
78.1 KB |
|
| |
Apr 17, 2012
NeoGenomics Schedules its Q1 2012 Earnings Release for April 25, 2012
|
31.1 KB |
|
| |
Mar 28, 2012
NeoGenomics Announces Increase in the Maximum Availability Under its Revolving Credit Facility
|
37.9 KB |
|
| |
Mar 5, 2012
NeoGenomics Announce Upward Revision to Q1 2012 Revenue Guidance
|
75.7 KB |
|
| |
Feb 16, 2012
NeoGenomics Reports 47% Revenue Growth and Profitability for Q4 2011; Provides Financial Outlook for 2012
|
114.3 KB |
|
| |
Feb 7, 2012
NeoGenomics Schedules its Q4 and Full Year 2011 Earnings Release for February 16, 2012
|
31.2 KB |
|
|
|
